Ginlix AI
50% OFF

Analysis Report on the Contrast Between Performance and Patents of Peicheng Technology (874553)

#IPO #北交所 #BMS #电池管理 #业绩分析 #专利 #技术竞争力 #科技股 #研发效率
Negative
A-Share
January 10, 2026

Unlock More Features

Login to access AI-powered analysis, deep research reports and more advanced features

Analysis Report on the Contrast Between Performance and Patents of Peicheng Technology (874553)

About us: Ginlix AI is the AI Investment Copilot powered by real data, bridging advanced AI with professional financial databases to provide verifiable, truth-based answers. Please use the chat box below to ask any financial question.

Related Stocks

874553
--
874553
--
301157.SZ
--
301157.SZ
--
832432.NQ
--
832432.NQ
--

I have now collected sufficient information. From the perspective of a professional financial analyst, let me conduct an in-depth analysis of the sustainability of the contrast between Peicheng Technology’s performance and its patent holdings.


Analysis Report on the Contrast Between Performance and Patents of Peicheng Technology (874553)
I. Company Overview

Peicheng Technology, full name “Shenzhen Peicheng Electronic Technology Co., Ltd.”, is an enterprise applying for an IPO on the Beijing Stock Exchange (BSE), with its core business being

the main control module in Battery Management Systems (BMS)
[1]. Founded in 2004, its actual controller is Yan Xiaohan, and its office is located in the North Zone of Science and Technology Park, Nanshan District, Shenzhen [2].


II. Performance Analysis: Hidden Concerns Behind Strong Growth
Outstanding Performance in the First Three Quarters of 2025

According to public financial data, Peicheng Technology achieved significant growth in the first three quarters of 2025:

Financial Indicator Value YoY Change
Total Operating Revenue RMB 885.5349 million +76.49%
Net Profit Attributable to Parent RMB 128.8575 million +114.83%
Non-GAAP Net Profit RMB 127.1435 million Not Disclosed
Earnings Per Share (EPS) RMB 2.58 per share
Gross Profit Margin 28.76%
Weighted Return on Equity (ROE) 27.10%

Data Source: [2][1]

However, this outstanding performance needs to be examined in conjunction with historical results:

Year Change in Operating Revenue Change in Net Profit Attributable to Parent
2023 -10.19% Not Disclosed
2024 -4.02% -17.58%
First Three Quarters of 2025 +76.49% +114.83%

Data Source: [1]

As can be seen from the table, Peicheng Technology faced performance pressures for two consecutive years in 2023 and 2024. The explosive growth in 2025 is more like

a rebound driven by the low-base effect
rather than a qualitative change in endogenous growth momentum.


III. Patent Status: Huge Gap with Peers
Comparison of Patent Counts

This is the core of the problem. As the earliest established (2004) BMS enterprise, Peicheng Technology’s patent accumulation lags far behind its later-established peers:

Company Founding Year Cumulative Patents Invention Patents
Peicheng Technology
2004
24
17
Huasu Technology (301157.SZ) 2005 54 42
Kelie Technology (832432.NQ) 2010 89 38

Data Source: [1]

Peicheng Technology’s patent count is only approximately:

  • 44%
    of Huasu Technology’s
  • 27%
    of Kelie Technology’s

More importantly, Peicheng Technology has far more R&D personnel than these two peers:

  • Peicheng Technology: 198 R&D personnel (accounting for 32.41%)
  • Huasu Technology: 88 R&D personnel
  • Kelie Technology: 148 R&D personnel

Data Source: [1]

This contrast of “more people, fewer patents” has aroused doubts in the market.


IV. Analysis of R&D Input-Output Efficiency
Comparison of Per Capita Patent Output
Company Number of R&D Personnel Per Capita Patents Per Capita Invention Patents
Peicheng Technology 198 0.12 per person 0.09 per person
Huasu Technology 88 0.61 per person 0.48 per person
Kelie Technology 148 0.60 per person 0.26 per person

Peicheng Technology’s per capita patent output efficiency is only about

20% of Huasu Technology’s
.

Comparison of R&D Personnel Compensation

Even more abnormal is the compensation level of R&D personnel:

Company Average Annual Salary of R&D Personnel Remarks
Peicheng Technology RMB 211,800 Planned Implementation Project
Kelie Technology RMB 428,600 2024 Actual

Data Source: [1]

Both companies are located in Nanshan District, Shenzhen, and operate in the same business field. The compensation of Peicheng Technology’s R&D personnel is only

49.4%
of Kelie Technology’s, which is approximately half.


V. Is This Contrast Sustainable?
Short-Term (1-2 Years): May Sustain but Risks Are Accumulating

Supporting Factors:

  1. Strong Market Demand
    : As a core link in the new energy industry chain, BMS benefits from the continuous growth of new energy vehicles and energy storage systems
  2. Capacity Expansion
    : In the first half of 2025, production personnel increased from 113 to 158, leading to a significant release of production capacity [1]
  3. Economies of Scale
    : The economies of scale brought by the 76.49% revenue growth may maintain profit margins in the short term

Risk Factors:

  1. Doubts about Labor Costs
    : The number of production personnel increased significantly but direct labor costs did not rise in tandem, indicating abnormal financial data [1]
  2. Customer Concentration
    : Not disclosed in the prospectus, but the BMS industry generally has the issue of high customer concentration
  3. Low-Base Effect
    : Performance declined in 2024, and part of the high growth in 2025 stems from the base effect
Mid-Term (3-5 Years): Faces Severe Challenges

Core Risk: Insufficient Technological Competitiveness

  1. Weak Patent Barriers
    : With only 24 patents, it is at a clear disadvantage in the BMS industry and struggles to build a technological moat
  2. Low R&D Efficiency
    : The output of its 198-person R&D team is far inferior to Huasu Technology’s 88-person team, indicating redundant personnel or management issues
  3. Intellectual Property Risk
    : Insufficient patents may lead to a passive position in patent litigation and exposure to infringement compensation risks

Industry Trends Are Unfavorable to Peicheng Technology:

  • BMS technology is developing towards high integration, intelligence, and connectivity, requiring continuous R&D investment
  • Leading vehicle and battery enterprises are developing their own BMS, accelerating technological iteration
  • Energy storage BMS has higher requirements for safety and consistency, and patent accumulation has become an access threshold
Long-Term (Over 5 Years): High Uncertainty
  • If it fails to make breakthroughs in patents and technology, it may be marginalized into a low-end contract manufacturer
  • After listing on the Beijing Stock Exchange, it will face stricter information disclosure and regulatory requirements
  • Under the registration-based system, the market’s screening of company quality will be more stringent

VI. Key Financial Doubts to Focus On

According to the prospectus disclosure, the following financial anomalies also exist [1]:

  1. Mismatch Between Labor Costs and Personnel Expansion

    • In the first half of 2025, production personnel increased from 113 to 158 (a 39.8% increase)
    • Product sales volume is close to the full-year 2024 level
    • But direct labor costs did not rise in tandem
  2. Doubts About R&D Expense Classification

    • R&D personnel account for 32.41%, far exceeding production personnel
    • Compensation is only half of that of peers
    • Patent output efficiency is extremely low

VII. Investment Recommendations and Risk Warnings
Risk Assessment
Risk Type Risk Level Description
Technological Risk
High
Patent count is far lower than peers, with weak technological barriers
Financial Risk
Medium-High
Abnormal labor cost data, doubts about the quality of information disclosure
Operational Risk
Medium
High performance volatility, sustainability is doubtful
Valuation Risk
Medium-High
IPO valuation may not reflect true technological value
Core Conclusion

The contrast between Peicheng Technology’s surging performance and its patent count far lower than peers

is not sustainable
. The reasons are as follows:

  1. Short-Term Rebound, Not a Turnaround
    : Performance declined for two consecutive years from 2023 to 2024, and part of the high growth in 2025 stems from the low-base effect
  2. Weak Technological Foundation
    : Only 24 patents cannot support long-term competitiveness in the BMS industry
  3. Doubts About R&D Efficiency
    : The output of its 198-person R&D team is far inferior to a peer’s 88-person team, indicating resource allocation issues
  4. Intensified Industry Competition
    : BMS technology iteration is accelerating, and patent accumulation will become a key competitive factor

VIII. References

[1] Sina Finance - “Peicheng Technology’s IPO: Lots of R&D Personnel, Low Salaries, Few Results, Isn’t That Strange?” (https://finance.sina.com.cn/stock/marketresearch/2026-01-09/doc-inhfsfzt4664407.shtml)

[2] Eastmoney - “Quick Overview of Peicheng Technology (874553) Stock” (https://xinsanban.eastmoney.com/F10/874553.html)


Analyst Note
: This report is compiled and analyzed based on public information and does not constitute investment advice. Investors should pay attention to the company’s subsequent information disclosures, especially the responses to inquiry letters during the Beijing Stock Exchange review process, to obtain more complete information.

Related Reading Recommendations
No recommended articles
Ask based on this news for deep analysis...
Alpha Deep Research
Auto Accept Plan

Insights are generated using AI models and historical data for informational purposes only. They do not constitute investment advice or recommendations. Past performance is not indicative of future results.